Thank you for your interest in TumorGenesis. Our TumorGenesis tumor modeling approach identifies biomarkers indicative of cancer by “fooling” cancer cells into thinking they’re still growing inside the patient. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolates and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

As a subsidiary company of Predictive Oncology, we invite you to also check out Predictive Oncology’s website by clicking on the link below. Or, continue on to TumorGenesis patient outcomes.